Autoimmune Hemolytic Anemia: Anticoagulation Study

We are testing whether prolonged anticoagulation therapy can help prevent blood clots in patients with autoimmune hemolytic anemia. This study will also look at how well patients tolerate the treatment and the timing of any clotting events.

>2 years ≤5 visits Efficacy phase (II)No Placebo Standard Medicines Oral InjectionHematologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Eliquis

Eliquis is a medicine that helps prevent harmful blood clots and lowers the risk of stroke.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Apixaban

Apixaban is a substance that helps prevent harmful blood clots and lowers stroke risk in people with irregular heart rhythm.

Enoxaparin Sodium

Enoxaparin sodium is a substance that helps prevent and treat blood clots by thinning the blood.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Abatixent

Abidalo

Aboxoma

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Centre Hospitalier Universitaire De Toulouse

Médecine interne

Blagnac, France

Centre Hospitalier Universitaire De Bordeaux

Médecine interne et Maladies Infectieuses

Canéjan, France

Centre Hospitalier William Morey

Hématologie-Oncologie

Chalon-sur-Saône, France

Sponsor: Centre Hospitalier Universitaire De Dijon

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.